Bio-Rad Laboratories, Inc. (BIO) vs Tempus AI, Inc. (TEM)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Tempus AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnBIO vs TEM

growth of $100 · dividends reinvested · last 2y
BIO +37.3% (+17.2%/yr)TEM +52.2% (+23.4%/yr)TEM compounded faster over this window
50100150200250Start $10020252026$137$152
BIO TEM

BIO vs TEM: by the numbers

  • TEM is the larger company ($10.34B vs $9.94B market cap).
  • BIO is profitable (8.59% net margin) while TEM runs a net loss (-17.77%).
  • TEM grew revenue faster over the past five years (38.24% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricBIOTEM
P/E ratio44.77N/A
Forward P/E38.31N/A
P/S ratio3.847.22
P/B ratio1.3923.24
EV / EBITDA27.78N/A
FCF yield3.55%N/A

Profitability

MetricBIOTEM
Gross margin51.90%63.98%
Operating margin9.08%-19.76%
Net margin8.59%-17.77%
ROE3.10%-57.18%
ROIC1.54%-14.34%

Growth (annualized)

MetricBIOTEM
Revenue CAGR (5Y)0.29%38.24%
EPS CAGR (5Y)-26.27%N/A
FCF CAGR (5Y)-9.65%N/A
Total return CAGR (5Y)-14.78%N/A

Frequently asked

Which has grown faster, BIO or TEM?
Over the past five years, TEM grew revenue faster — BIO at a 0.29% CAGR versus TEM at 38.24%.
Is BIO or TEM more profitable?
BIO runs the higher net margin — BIO at 8.59% versus TEM at -17.77%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.